u/Darkguard1733 5.0 6 ideas

NVDA passes the author's fundamental and moat criteria but is considered a "special case" due to potential overvaluation from AI hype and optimistic revenue projections. The semiconductor sector also appears technically near a peak. The current valuation and technical picture present an unfavorable risk/reward profile. A significant price correction would be needed to offer a better entry point that aligns with the author's risk management principles. The author is explicitly avoiding NVDA at its current price, preferring to wait for a potential drop to around $150 or a P/E ratio of ~25 before considering an investment. The primary risk is opportunity cost. The AI trend could be stronger and more sustained than anticipated, causing NVDA's stock to continue rising without providing the desired entry point.

Adobe (ADBE) is listed as a "Wide Moat" company that has passed both stages of the author's fundamental analysis screening. It is also explicitly identified as "Undervalued" based on the author's P/E framework. By passing the author's strict quality and valuation filters, ADBE is identified as a high-quality company potentially available at an attractive price, making it a prime candidate for a long position. ADBE is a strong candidate for the author's portfolio, pending a qualitative check for conviction and a favorable entry point determined by technical analysis. The screening is based on historical data; future fundamentals could weaken. The moat could be challenged by new competitors or technological shifts (e.g., generative AI).

Microsoft (MSFT) is categorized as a "Wide Moat" company that has successfully passed the author's two-stage fundamental screening process. It is also highlighted on the "Undervalued" list. The combination of a strong competitive advantage (wide moat), solid fundamentals, and an attractive valuation makes MSFT a high-priority investment candidate according to the author's system. MSFT is a top-tier company on the author's watchlist. An investment is contingent upon the author's personal conviction and finding an optimal entry point via technical analysis. Regulatory scrutiny could impact growth. The valuation, while deemed attractive by the author's framework, could still be high by other metrics. Competition in cloud and AI remains intense.

Johnson & Johnson (JNJ) is identified as a "Wide Moat" company that passed the author's fundamental screens and is also explicitly listed as "Undervalued." As a high-quality, defensive company with a strong moat trading at what the author considers an undervalued price, JNJ fits the core criteria of the investment framework for a long-term holding. JNJ is a prime candidate for inclusion in the author's portfolio, subject to a final qualitative review and a technically opportune entry point. Ongoing litigation risks (e.g., talc lawsuits) could create headline risk and financial liabilities. The pharmaceutical pipeline's success is uncertain and crucial for future growth.

INTU is presented as an example of a stock that passed the author's fundamental and valuation screens but experienced a technical breakdown, breaking below its trendline. This technical breakdown, despite strong fundamentals, creates a potential buying opportunity at lower, predefined support zones. The author suggests using Dollar-Cost Averaging (DCA) into these zones. INTU is a fundamentally strong company that has become technically attractive for accumulation. The strategy is to buy into weakness at established support levels rather than chasing momentum. The trendline break could signal a longer-term reversal in investor sentiment, not just a temporary pullback. The fundamental picture could change, or the support zones may not hold.

FDS is cited alongside INTU as a company that fits the author's framework but has recently broken its upward trendline on a technical chart. The author's methodology explicitly states that when a trendline breaks on a fundamentally sound and fairly valued company, the "next best move was DCA into support zones." This indicates a planned entry strategy on weakness. FDS represents a high-quality business, according to the author's screening, that is offering a potentially attractive entry point for patient investors who can accumulate shares at lower support levels. A technical breakdown could be the leading indicator of deteriorating fundamentals not yet reflected in the trailing data used for screening. The stock could continue to fall through multiple support levels.